A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients

Clinical trial NCT02017717 · COMPLETED

Trial details

NCT number: NCT02017717
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Glioblastoma

Start date: 2014-02-07
Primary completion: 2019-06-17
Enrollment: 529

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.